DELAYED COMPLICATIONS OF VOLUNTEER UNRELATED DONOR BONE-MARROW TRANSPLANTATION (VUD-BMT)

被引：0
|
作者：
FUNG, H
BARNETT, M
REECE, D
KLINGEMANN, H
SHEPHERD, J
NANTEL, S
SUTHERLAND, H
SPINELLI, J
PHILLIPS, G
机构：
[1] VANCOUVER HOSP & HLTH SCI CTR,BRITISH COLUMBIA CANC AGCY,LEUKEMIA BMT PROGRAM BRITISH COLUMBIA,VANCOUVER,BC,CANADA
[2] UNIV BRITISH COLUMBIA,VANCOUVER V6T 1W5,BC,CANADA
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A492 / A492
页数：1
相关论文
共 50 条
  • [21] PREGNANCIES AND OFFSPRING COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION (BMT)
    HINTERBERGERFISCHER, M
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1991, 141 (9-10) : 228 - 231
  • [22] Impact of donor leucocyte infusions on outcome after T cell depleted volunteer unrelated donor (VUD) bone marrow transplantation in patients with CML.
    Craddock, C
    Dazzi, F
    Szydlo, R
    Cwynarski, K
    Olavarria, E
    Brookes, P
    Kanfer, E
    Apperley, J
    Goldman, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 32 - 32
  • [23] Unrelated donor (URD) bone marrow transplantation (BMT) for refractory anemia (RA).
    Bjerke, J
    Anasetti, C
    Gooley, T
    Appelbaum, F
    Hansen, J
    Anderson, J
    Slattery, J
    Storb, R
    Deeg, HJ
    BLOOD, 1998, 92 (10) : 142A - 142A
  • [24] UNRELATED DONOR BONE-MARROW TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA
    MCGLAVE, P
    ARTHUR, D
    BLAZAR, B
    FILIPOVICH, A
    KRIVIT, W
    MCCULLOUGH, J
    RAMSAY, N
    KERSEY, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 181 - 181
  • [25] BONE-MARROW TRANSPLANTATION FROM UNRELATED DONOR IN MYELODYSPLASTIC SYNDROMES
    ALESSANDRINO, EP
    BERNASCONI, P
    BONFICHI, M
    CALDERA, D
    CAMPAGNOLI, C
    BONI, M
    BERNASCONI, C
    BONE MARROW TRANSPLANTATION, 1993, 11 : 71 - 73
  • [26] UNRELATED BONE-MARROW TRANSPLANTATION
    ROCK, GA
    TRANSFUSION SCIENCE, 1991, 12 (03): : 109 - 109
  • [27] Immune recovery following unrelated or family donor bone marrow transplantation (BMT).
    Fehse, N
    Zabelina, T
    Kröger, N
    Fehse, B
    Kabisch, H
    Zeller, W
    Pichlmeier, U
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1999, 23 : S228 - S228
  • [28] HEMATOLOGIC AND IMMUNOLOGICAL RECONSTITUTION FOLLOWING UNRELATED DONOR (URD) BONE-MARROW TRANSPLANTATION (BMT) FOR LETHAL IMMUNODEFICIENCIES (ID)
    FILIPOVICH, AH
    SHAPIRO, RS
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 571 - 571
  • [29] HLA AND BONE-MARROW TRANSPLANTATION (BMT)
    GOLDMANN, SF
    KLINISCHE PADIATRIE, 1981, 193 (03): : 266 - 271
  • [30] IMMUNOTOXINS (IT) IN BONE-MARROW TRANSPLANTATION (BMT)
    VALLERA, DA
    UCKUN, FM
    KERSEY, JH
    FILIPOVICH, AH
    MYERS, DE
    BLAZAR, BR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 210 - 210
12345